CN Patent

CN102584788A — 3-(4-氨基-1-氧代-1,3 二氢-异吲哚-2-基)-哌啶-2,6-二酮的水合物

Assigned to Celgene Corp · Expires 2012-07-18 · 14y expired

What this patent protects

本发明公开了晶体3-(4-氨基-1-氧代-1，3二氢-异吲哚-2-基)-哌啶-2，6-二酮的半水合物和二水合物。还公开了晶体3-(4-氨基-1-氧代-1，3二氢-异吲哚-2-基)-哌啶-2，6-二酮的半水合物和二水合物的制备方法，其包括在水中浆化3-(4-氨基-1-氧代-1，3二氢-异吲哚-2-基)-哌啶-2，6-二酮、过滤并干燥。

USPTO Abstract

本发明公开了晶体3-(4-氨基-1-氧代-1，3二氢-异吲哚-2-基)-哌啶-2，6-二酮的半水合物和二水合物。还公开了晶体3-(4-氨基-1-氧代-1，3二氢-异吲哚-2-基)-哌啶-2，6-二酮的半水合物和二水合物的制备方法，其包括在水中浆化3-(4-氨基-1-氧代-1，3二氢-异吲哚-2-基)-哌啶-2，6-二酮、过滤并干燥。

Drugs covered by this patent

Patent Metadata

Patent number
CN102584788A
Jurisdiction
CN
Classification
—
Expires
2012-07-18
Drug substance claim
No
Drug product claim
No
Assignee
Celgene Corp
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.